BOUNDLESS BIO, INC. (BOLD) Free cash flow 2023–2025
BOUNDLESS BIO, INC. (BOLD) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$47.2MFY2025 · since FY2023: -$47.5M → -$47.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$47.2M | +25.5% |
| FY2024 | -$63.4M | -33.5% |
| FY2023 | -$47.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More BOLD financial trends
BOLD RevenueBOLD Net incomeBOLD Net marginBOLD Gross profitBOLD Gross marginBOLD Operating incomeBOLD Operating marginBOLD Operating cash flowBOLD Capital expendituresBOLD Return on equityBOLD Stock buybacksBOLD Dividends paidBOLD Total assetsBOLD Total liabilitiesBOLD Shareholders’ equityBOLD overview →